Cresco Labs CRLBF
OTC CRLBF
$0.82 +0.04 (+4.94%)
At close: Aug 19, 2026 · 3:30 PM UTC

Cresco Labs (CRLBF) Other Non-Current Liabilities (2019 - 2026)

Cresco Labs' (CRLBF) quarterly Other Non-Current Liabilities came in at $184.9 million in Q1 2026, up 36.15% YoY from $135.8 million in Q1 2025, and up 7.83% on a QoQ basis from $171.5 million in Q4 2025.

Cresco Labs (CRLBF) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

Cresco Labs (CRLBF) has 8 years of Other Non-Current Liabilities data on file, last reported at $184.9 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 36.15% year-over-year to $184.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.9 million (up 36.15% YoY) and the FY2025 annual result came in at $171.5 million, changed N/A from the prior year.
  • Other Non-Current Liabilities advanced to $184.9 million in Q1 2026, from $171.5 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $184.9 million in Q1 2026 to a low of $7.0 million in Q1 2022.
  • A 5-year average of $97.2 million and a median of $136.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities fell 18.14% — and 2025, when it jumped 522.14%.
  • Tracing CRLBF's Other Non-Current Liabilities over 5 years: stood at $12.9 million in 2022, then surged by 56.67% to $20.2 million in 2023, then surged by 658.94% to $153.4 million in 2024, then grew by 11.79% to $171.5 million in 2025, then gained by 7.83% to $184.9 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $184.9 million (Q1 2026), $171.5 million (Q4 2025), and $165.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 43.08 Bn 39.43 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.87 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn
5 United Therapeutics 22.12 Bn 19.46 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn -
10 Cresco Labs 292.94 Mn 228.83 Mn 86.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 184.91 Mn
Dec 31, 2025 171.47 Mn
Sep 30, 2025 165.16 Mn
Jun 30, 2025 150.54 Mn
Mar 31, 2025 135.81 Mn
Sep 30, 2024 153.40 Mn
Jun 30, 2024 136.64 Mn
Mar 31, 2024 21.83 Mn
Dec 31, 2023 20.21 Mn
Dec 31, 2022 12.90 Mn
Jun 30, 2022 7.01 Mn
Mar 31, 2022 7.01 Mn
Dec 31, 2021 7.00 Mn
Sep 30, 2021 7.04 Mn
Mar 31, 2021 8.56 Mn
Dec 31, 2020 8.56 Mn
Dec 31, 2019 15.24 Mn